Increased levels of the checkpoint cytokines IL-33 and ILC2 frequencies were detected in the serum and plasma of patients with moderate COVID-19 [69], while decreased ILC2 frequencies were observed in severe patients [70,71], indicating that ILC2 may be involved in COVID-19 pathology. The gene discussed is IL33; the disease is COVID-19.